RhumbLine Advisers’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-345,130
Closed -$244K 4225
2025
Q1
$244K Buy
345,130
+20,655
+6% +$14.3K ﹤0.01% 3007
2024
Q4
$261K Buy
324,475
+37,034
+13% +$33.9K ﹤0.01% 3072
2024
Q3
$285K Sell
287,441
-13,777
-5% -$18.9K ﹤0.01% 3051
2024
Q2
$467K Buy
301,218
+291,625
+3,040% +$454K ﹤0.01% 2732
2024
Q1
$15.7K Hold
9,593
﹤0.01% 3798
2023
Q4
$5.51K Hold
9,593
﹤0.01% 3962
2023
Q3
$3.84K Sell
9,593
-7,435
-44% -$3.67K ﹤0.01% 4024
2023
Q2
$9.25K Sell
17,028
-271,023
-94% -$174K ﹤0.01% 3971
2023
Q1
$246K Buy
288,051
+10,154
+4% +$11.1K ﹤0.01% 2678
2022
Q4
$361K Buy
277,897
+9,578
+4% +$14.9K ﹤0.01% 2603
2022
Q3
$478K Buy
268,319
+18,829
+8% +$46.9K ﹤0.01% 2514
2022
Q2
$566K Buy
249,490
+56,992
+30% +$136K ﹤0.01% 2435
2022
Q1
$635K Sell
192,498
-842
-0.4% -$2.96K ﹤0.01% 2311
2021
Q4
$880K Sell
193,340
-2,810
-1% -$21.2K ﹤0.01% 2259
2021
Q3
$1.41M Buy
196,150
+4,665
+2% +$34.2K ﹤0.01% 2074
2021
Q2
$1.54M Buy
+191,485
New +$1.62M ﹤0.01% 2068

Other funds holding OCGN

RhumbLine Advisers's OCGN Position: Q2 2025 in Review

RhumbLine Advisers sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 345,130 shares — an estimated $244K sold.

RhumbLine Advisers first reported a position in OCGN in Q2 2021 and held it in 16 quarters. The position peaked at $1.54M in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • RhumbLine Advisers reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 345,130 Ocugen shares in Q2 2025, an estimated $244K.
  • RhumbLine Advisers first reported a position in Ocugen in Q2 2021 and held it in 16 quarters.
  • RhumbLine Advisers's Ocugen position peaked at $1.54M in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.